S100A4 inhibitors significantly reduced epidermal hyperplasia and dermal vascularization and impaired keratinocyte proliferation in an animal model of psoriasis [41], suggesting that S100A4 positively regulates skin inflammation in psoriasis. The gene discussed is S100A4; the disease is psoriasis.